Logo

PrecisionMed and Phenomenome Discoveries to Co-Develop Metabolite-Based Diagnostics for Alzheimer s, Bipolar Disorder

Feb 04, 2005

NEW YORK, Feb. 4 (GenomeWeb News) - PrecisionMed and Phenomenome Discoveries will collaborate to develop diagnostics for Alzheimer's disease and bipolar disorder, the companies said today.

 

Phenomenome, based in Saskatoon, Canada, will contribute its metabolomics technology to find metabolites that differ between patients and controls.

 

PrecisionMed, a human biobank located in San Diego, will provide clinical samples and information.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.